Patient leaflet - SINGULAIR 10 MG FILM-COATED TABLETS
Singulair® 10 mg
(montelukast sodium)
2305
21.05.20[11]
PATIENT INFORMATION LEAFLET
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
-
– Keep this leaflet. You may need to read it again.
-
– If you have any further questions, ask your doctor or pharmacist.
-
– This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
-
– If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4.
Your medicine is available using the above name but will be referred to as Singulair throughout this leaflet.
What is in this leaflet:
-
1. What Singulair is and what it is used for
-
2. What you need to know before you take Singulair
-
3. How to take Singulair
-
4. Possible side effects
-
5. How to store Singulair
-
6. Contents of the pack and other information
1. what singulair is and what it is used for
What Singulair is
Singulair is a leukotriene receptor antagonist that blocks substances called leukotrienes.
How Singulair works
Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms. By blocking leukotrienes, Singulair improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).
When Singulair should be used
Your doctor has prescribed Singulair to treat asthma, preventing your asthma symptoms during the day and night.
-
– Singulair is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled on their medication and need additional therapy.
-
– Singulair also helps prevent the narrowing of airways triggered by exercise.
-
– In those asthmatic patients in whom Singulair is indicated in asthma, Singulair can also provide symptomatic relief of seasonal allergic rhinitis.
Your doctor will determine how Singulair should be used depending on the symptoms and severity of your asthma.
What is asthma?
Asthma is a long-term disease.
Asthma includes:
-
– difficulty breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.
-
– sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.
-
– swelling (inflammation) in the lining of airways.
Symptoms of asthma include: Coughing, wheezing, and chest tightness.
What are seasonal allergies?
Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic response often caused by airborne pollens from trees, grasses and weeds. The symptoms of seasonal allergies typically may include: stuffy, runny, itchy nose; sneezing; watery, swollen, red, itchy eyes.
2. what you need to know before you take singulair
Tell your doctor about any medical problems or allergies you have now or have had.
Do not take Singulair
-
– if you are allergic to montelukast or any of the other ingredients of this medicine (listed in Section 6).
Warnings and precautions
Talk to your doctor or pharmacist before taking Singulair.
-
– If your asthma or breathing gets worse, tell your doctor immediately.
-
– Oral Singulair is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you. Always have your inhaled rescue medicine for asthma attacks with you.
-
– It is important that you or your child take all asthma medications prescribed by your doctor. Singulair should not be substituted for other asthma medications your doctor has prescribed for you.
-
– Any patient on anti-asthma medicines should be aware that if you develop a combination of symptoms such as a flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms and/or rash, you should consult your doctor.
-
– You should not take acetyl-salicylic acid (aspirin) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they make your asthma worse.
Patients should be aware that various neuropsychiatric events (for example behaviour and mood-related changes) have been reported in adults, adolescents and children with Singulair (see Section 4). If you develop such symptoms while taking Singulair, you should consult your doctor.
Children and adolescents
Do not give this medicine to children less than 15 years of age.
There are different form(s) of this medicine available for paediatric patients under 18 years of age based on age range.
Other medicines and Singulair
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines including those obtained without a prescription.
Some medicines may affect how Singulair works, or Singulair may affect how other medicines work.
Tell your doctor if you are taking the following medicines before starting Singulair:
-
– phenobarbital (used for treatment of epilepsy)
-
– phenytoin (used for treatment of epilepsy)
-
– rifampicin (used to treat tuberculosis and some other infections)
-
– gemfibrozil (used for treatment of high lipid levels in plasma)
Singulair with food and drink
Singulair 10 mg film-coated tablet may be taken with or without food.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Singulair.
Pregnancy
Your doctor will assess whether you can take Singulair during this time. Breast-feeding
It is not known if Singulair appears in breast milk. You should consult your doctor before taking Singulair if you are breast-feeding or intend to breastfeed.
Driving and using machines
Singulair is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported with Singulair may affect some patients’ ability to drive or operate machinery.
Singulair 10 mg film-coated tablets contain lactose and sodium
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
This medicine contains less than 1 mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’.
3. how to take singulair
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
- You should take only one tablet of Singulair once a day as prescribed by your doctor.
- It should be taken even when you have no symptoms or have an acute asthma attack.
For adults and adolescents 15 years of age and older:
The recommended dose is one 10 mg tablet to be taken daily in the evening.
If you are taking Singulair, be sure that you do not take any other products that contain the same active ingredient, montelukast.
This medicine is for oral use.
You can take Singulair 10 mg with or without food.
If you take more Singulair than you should
Contact your doctor immediately for advice.
There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.
If you forget to take Singulair
Try to take Singulair as prescribed. However, if you miss a dose, just resume the usual schedule of one tablet once daily.
Do not take a double dose to make up for a forgotten dose.
If you stop taking Singulair
Singulair can treat your asthma only if you continue to take it.
It is important to continue taking Singulair for as long as your doctor prescribes. It will help control your asthma.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In clinical studies with Singulair 10 mg film-coated tablets, the most commonly reported side effects (may affect up to 1 in 10 people) thought to be related to Singulair were:
-
– abdominal pain
-
– headache
These were usually mild and occurred at a greater frequency in patients treated with Singulair than placebo (a pill containing no medication).
Serious side effects
Talk with your doctor immediately if you notice any of the following side effects, which may be serious, and for which you may need urgent medical treatment.
Uncommon: the following may affect up to 1 in 100 people
-
– allergic reactions including swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing
-
– behaviour and mood related changes: agitation including aggressive behaviour or hostility, depression
-
– seizure
Rare: the following may affect up to 1 in 1,000 people
-
– increased bleeding tendency
-
– tremor
-
– palpitations
Very rare: the following may affect up to 1 in 10,000 people
-
– combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) (see Section 2)
-
– low blood platelet count
-
– behaviour and mood related changes: hallucinations, disorientation, suicidal thoughts and actions
-
– swelling (inflammation) of the lungs
-
– severe skin reactions (erythema multiforme) that may occur without warning
-
– inflammation of the liver (hepatitis)
Other side effects while the medicine has been on the market
Very common: the following may affect more than 1 in 10 people
-
– upper respiratory infection
Common: the following may affect up to 1 in 10 people
-
– diarrhoea, nausea, vomiting
-
– rash
-
– fever
-
– elevated liver enzymes
Uncommon: the following may affect up to 1 in 100 people
-
– behaviour and mood related changes: dream abnormalities, including nightmares, trouble sleeping, sleepwalking, irritability, feeling anxious, restlessness
-
– dizziness, drowsiness, pins and needles/numbness
-
– nosebleed
-
– dry mouth, indigestion
-
– bruising, itching, hives
-
– joint or muscle pain, muscle cramps
-
– bedwetting in children
-
– weakness/tiredness, feeling unwell, swelling
Rare: the following may affect up to 1 in 1,000 people
-
– behaviour and mood related changes: disturbance in attention, memory impairment, uncontrolled muscle movements
Very rare: the following may affect up to 1 in 10,000 people
-
– tender red lumps under the skin, most commonly on your shins (erythema nodosum)
-
– behaviour and mood related changes: obsessive-compulsive symptoms, stuttering
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at:or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. how to store singulair
-
– Keep out of the sight and reach of children.
-
– Do not store above 30o C. Store in the original package.
-
– Do not give the tablets to your child if they have passed the expiry date, which is clearly marked on the pack.
-
– If your doctor tells you to stop taking this medicine, return any unused tablets to your doctor for safe disposal. Only keep the tablets if your doctor tells you to.
-
– If your tablets become discoloured or show any other signs of deterioration, consult your doctor or pharmacist who will tell you what to do.
-
– Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. contents of the pack and other information
What Singulair contains
The active ingredient in Singulair is montelukast (montelukast sodium).
Each film-coated tablet contains montelukast sodium equivalent to 10 mg montelukast.
The other ingredients are: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, hydroxypropylcellulose (E463), magnesium stearate, hypromellose, titanium dioxide (E171), red ferric oxide (E 172) and yellow ferric oxide (E172) and carnauba wax
What Singulair looks like and contents of the pack
Singulair are beige, rounded square, film-coated tablets with ‚SINGULAIR‘ engraved on one side and ‚MSD 117‘ on the other.
Blister pack size: 28 tablets.
Manufacturer and Product Licence Holder
Singulair is manufactured by Merck Sharp & Dohme Ltd, Shotton Lane, Cramlington, Northumberland NE23 3JU, UK.
Procured from within the EU by product licence holder Star Pharmaceuticals Ltd, 5 Sandridge Close, Harrow, Middlesex, HA1 1XD. Repackaged by Servipharm Ltd.
| POM | | PL 20636/2305 |
Leaflet revision and issue date (Ref) 21.05.20[11]
Singulair is trademark of Merck & Co., Inc.,
Information is given by:
Asthma UK, 18 Mansell Street, London E1 8AA. Alternatively phone the Asthma UK Helpline on 0300 222 5800, Monday to Friday 9 am to 5 pm, calls charged at the local rate.
(Asthma UK is an independent charity working to conquer asthma and is not associated with Merck Sharp & Dohme Limited.)
Blind or partially sighted?
Is this leaflet hard to see or read?
Call 020 8423 2111 to obtain leaflet in a format suitable for you.